Clinicopathological Significance and Prognostic Role of High Mobility Group Box 1 (HMGB1), Toll-Like Receptor (TLR) 2 and TLR4 in Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinicopathological Significance and Prognostic Role of High Mobility Group Box 1 (HMGB1), Toll-Like Receptor (TLR) 2 and TLR4 in Breast Cancer

Published:2024-04-25 Issue:2 Volume:57 Page:75-83
ISSN:0044-5991
Container-title:ACTA HISTOCHEMICA ET CYTOCHEMICA
language:en
Short-container-title:Acta Histochem. Cytochem.

Author:

Taguchi Reina¹,Yamaguchi-Tanaka Mio¹²,Takagi Kiyoshi¹,Sato Ai¹,Miki Yasuhiro³,Miyashita Minoru⁴,Suzuki Takashi¹³⁵

Affiliation:

1. Department of Pathology and Histotechnology, Tohoku University Graduate School of Medicine

2. Department of Personalized Medicine Center, Tohoku University Hospital

3. Department of Anatomic Pathology, Tohoku University Graduate School of Medicine

4. Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine

5. Department of Pathology, Tohoku University Hospital

Publisher

Japan Society of Histochemistry & Cytochemistry

Link

https://www.jstage.jst.go.jp/article/ahc/57/2/57_24-00006/_pdf

Reference43 articles.

1. 1 Amornsupak, K., Jamjuntra, P., Warnnissorn, M., O-Charoenrat, P., Sa-Nguanraksa, D., Thuwajit, P., et al. (2017) High ASMA+ Fibroblasts and Low Cytoplasmic HMGB1+ Breast Cancer Cells Predict Poor Prognosis. Clin. Breast Cancer 17; 441–452.e2.

2. 2 Beilmann-Lehtonen, I., Böckelman, C., Mustonen, H., Koskensalo, S., Hagström, J. and Haglund, C. (2020) The prognostic role of tissue TLR2 and TLR4 in colorectal cancer. Virchows Arch. 477; 705–715.

3. 3 Chen, X., Cheng, F., Liu, Y., Zhang, L., Song, L., Cai, X., et al. (2019) Toll-like receptor 2 and Toll-like receptor 4 exhibit distinct regulation of cancer cell stemness mediated by cell death-induced high-mobility group box 1. EBioMedicine. 40; 135–150.

4. 4 Dasu, M. R., Devaraj, S., Park, S. and Jialal, I. (2010) Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33; 861–868.

5. 5 Di Lorenzo, A., Bolli, E., Ruiu, R., Ferrauto, G., Di Gregorio, E., Avalle, L., et al. (2022) Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy. Oncoimmunology 11; 2086752.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological significance of hyaluronan and hyaluronidase 2 (HYAL2) in breast cancer;Pathology - Research and Practice;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3